OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS
Rui Wang, Huaixing Kang, Xu Zhang, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Rui Wang, Huaixing Kang, Xu Zhang, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers
Milena Matuszczak, Adam Kiljańczyk, Maciej Salagierski
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8597-8597
Open Access | Times Cited: 41
Milena Matuszczak, Adam Kiljańczyk, Maciej Salagierski
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8597-8597
Open Access | Times Cited: 41
Carotenoids in Health as Studied by Omics-Related Endpoints
Torsten Bohn, Emilio Balbuena, Hande Z. Ulus, et al.
Advances in Nutrition (2023) Vol. 14, Iss. 6, pp. 1538-1578
Open Access | Times Cited: 22
Torsten Bohn, Emilio Balbuena, Hande Z. Ulus, et al.
Advances in Nutrition (2023) Vol. 14, Iss. 6, pp. 1538-1578
Open Access | Times Cited: 22
Unmasking the Metabolite Signature of Bladder Cancer: A Systematic Review
Francisca Pereira, M. Rosário M. Domingues, Rui Vitorino, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3347-3347
Open Access | Times Cited: 5
Francisca Pereira, M. Rosário M. Domingues, Rui Vitorino, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3347-3347
Open Access | Times Cited: 5
Advancing Bladder Cancer Biomarker Discovery: Integrating Mass Spectrometry and Molecular Imaging
Vadanasundari Vedarethinam
Onco (2025) Vol. 5, Iss. 2, pp. 13-13
Open Access
Vadanasundari Vedarethinam
Onco (2025) Vol. 5, Iss. 2, pp. 13-13
Open Access
Bladder cancer biomarkers
Dominik Godlewski, Dorota Bartusik‐Aebisher, Sara Czech, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Dominik Godlewski, Dorota Bartusik‐Aebisher, Sara Czech, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Utilizing serum metabolomics for assessing postoperative efficacy and monitoring recurrence in gastric cancer patients
Tong Qu, Shaopeng Zhang, Shaokang Yang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Tong Qu, Shaopeng Zhang, Shaokang Yang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications
Siyu Wu, Rong Li, Yuan‐Hong Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115027-115027
Open Access | Times Cited: 10
Siyu Wu, Rong Li, Yuan‐Hong Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115027-115027
Open Access | Times Cited: 10
Urine‐based liquid biopsy in bladder cancer: Opportunities and challenges
Gang Wang, Wan Jin, Zilin Xu, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 9
Gang Wang, Wan Jin, Zilin Xu, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 9
Advancements in Bladder Cancer Management: A Comprehensive Review of Artificial Intelligence and Machine Learning Applications
Manu Sudhi, Vinod Kumar Shukla, Dasharathraj K Shetty, et al.
Engineered Science (2023)
Open Access | Times Cited: 9
Manu Sudhi, Vinod Kumar Shukla, Dasharathraj K Shetty, et al.
Engineered Science (2023)
Open Access | Times Cited: 9
Targeted quantitative metabolomics with a linear mixed-effect model for analysis of urinary nucleosides and deoxynucleosides from bladder cancer patients before and after tumor resection
Małgorzata Artymowicz, Wiktoria Struck‐Lewicka, Paweł Wiczling, et al.
Analytical and Bioanalytical Chemistry (2023) Vol. 415, Iss. 22, pp. 5511-5528
Open Access | Times Cited: 7
Małgorzata Artymowicz, Wiktoria Struck‐Lewicka, Paweł Wiczling, et al.
Analytical and Bioanalytical Chemistry (2023) Vol. 415, Iss. 22, pp. 5511-5528
Open Access | Times Cited: 7
Urinary microbiome dysbiosis is associated with an inflammatory environment and perturbed fatty acids metabolism in the pathogenesis of bladder cancer
Cen Wu, Xiaoyu Wei, Zhiyang Huang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Cen Wu, Xiaoyu Wei, Zhiyang Huang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Microbiome and bladder cancer: the role of probiotics in treatment
Leila Dadgar-Zankbar, Maryam Mokhtaryan, Elnaz Bafandeh, et al.
Future Microbiology (2024) Vol. 20, Iss. 1, pp. 73-90
Closed Access | Times Cited: 2
Leila Dadgar-Zankbar, Maryam Mokhtaryan, Elnaz Bafandeh, et al.
Future Microbiology (2024) Vol. 20, Iss. 1, pp. 73-90
Closed Access | Times Cited: 2
Urinary Metabolic Biomarker Profiling for Cancer Diagnosis by Terahertz Spectroscopy: Review and Perspective
Andreja Abina, Tjaša Korošec, Uroš Puc, et al.
Photonics (2023) Vol. 10, Iss. 9, pp. 1051-1051
Open Access | Times Cited: 6
Andreja Abina, Tjaša Korošec, Uroš Puc, et al.
Photonics (2023) Vol. 10, Iss. 9, pp. 1051-1051
Open Access | Times Cited: 6
Identification of Diagnostic Biomarkers for Compensatory Liver Cirrhosis Based on Gut Microbiota and Urine Metabolomics Analyses
Yingjun Chen, Shaoxian Chen, Chandi Xu, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 11, pp. 3164-3181
Open Access | Times Cited: 6
Yingjun Chen, Shaoxian Chen, Chandi Xu, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 11, pp. 3164-3181
Open Access | Times Cited: 6
13C Natural Isotope Abundance in Urothelium as a New Marker in the Follow-Up of Patients with Bladder Cancer
Adam Madej, Ewa Forma, Michał Golberg, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2423-2423
Open Access | Times Cited: 8
Adam Madej, Ewa Forma, Michał Golberg, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2423-2423
Open Access | Times Cited: 8
LC-MS based urine untargeted metabolomic analyses to identify and subdivide urothelial cancer
Ming Yang, Xiaoyan Liu, Xiaoyue Tang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Ming Yang, Xiaoyan Liu, Xiaoyue Tang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Advances in Liquid Biopsy for Diagnosis of Bladder Cancer
Jaekwon Seok, Yeonjoo Kwak, Sewhan Kim, et al.
International Neurourology Journal (2024) Vol. 28, Iss. 2, pp. 83-95
Open Access | Times Cited: 1
Jaekwon Seok, Yeonjoo Kwak, Sewhan Kim, et al.
International Neurourology Journal (2024) Vol. 28, Iss. 2, pp. 83-95
Open Access | Times Cited: 1
UPLC-Q-TOF/MS-based urine metabolomics for the diagnosis and staging of bladder cancer
Xingyu Shi, Wenbin Zheng, Binhong He, et al.
Clinica Chimica Acta (2024) Vol. 565, pp. 120022-120022
Closed Access | Times Cited: 1
Xingyu Shi, Wenbin Zheng, Binhong He, et al.
Clinica Chimica Acta (2024) Vol. 565, pp. 120022-120022
Closed Access | Times Cited: 1
The role of microbiota in tumorigenesis, progression and treatment of bladder cancer
Zijing Peng, Jingming Zhuang, Bing Shen
Microbiome Research Reports (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 2
Zijing Peng, Jingming Zhuang, Bing Shen
Microbiome Research Reports (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 2
Contribution of metabolomics in the discovery of biomarker for urinary bladder cancer
Dinesh Kumar Sahu, Vikrant Sharma
Elsevier eBooks (2024), pp. 1-11
Closed Access
Dinesh Kumar Sahu, Vikrant Sharma
Elsevier eBooks (2024), pp. 1-11
Closed Access
The Fire Fighter Cancer Cohort Study: Protocol for a Longitudinal Occupational Cohort Study of United States Firefighters (Preprint)
Jefferey L. Burgess, Shawn C. Beitel, Miriam M. Calkins, et al.
(2024)
Closed Access
Jefferey L. Burgess, Shawn C. Beitel, Miriam M. Calkins, et al.
(2024)
Closed Access
Urine Biomarkers for Bladder Cancer Diagnosis and Screening
Richard T. Bryan, Douglas G. Ward
(2024), pp. 371-392
Closed Access
Richard T. Bryan, Douglas G. Ward
(2024), pp. 371-392
Closed Access
The Fire Fighter Cancer Cohort Study: Protocol for a Longitudinal Occupational Cohort Study of United States Firefighters (Preprint)
Jefferey L. Burgess, Shawn C. Beitel, Miriam M. Calkins, et al.
JMIR Research Protocols (2024)
Open Access
Jefferey L. Burgess, Shawn C. Beitel, Miriam M. Calkins, et al.
JMIR Research Protocols (2024)
Open Access
Untargeted Metabolomic Profiling of Aqueous and Lyophilized Pooled Human Feces from Two Diet Cohorts Using Two-Dimensional Gas Chromatography Coupled with Time-of-Flight Mass Spectrometry
Seo Lin Nam, Kieran Tarazona Carrillo, A. Paulina de la Mata, et al.
Metabolites (2023) Vol. 13, Iss. 7, pp. 828-828
Open Access | Times Cited: 1
Seo Lin Nam, Kieran Tarazona Carrillo, A. Paulina de la Mata, et al.
Metabolites (2023) Vol. 13, Iss. 7, pp. 828-828
Open Access | Times Cited: 1
Liquid biopsies for detection, surveillance, and prognosis of urothelial cancer: a future standard?
Igor Duquesne, Mohamad Abou Chakra, Lory Hage, et al.
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 9, pp. 995-1007
Closed Access | Times Cited: 1
Igor Duquesne, Mohamad Abou Chakra, Lory Hage, et al.
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 9, pp. 995-1007
Closed Access | Times Cited: 1
